United Laboratories International Holdings Ltd

The United Laboratories International Holdings Limited is an investment holding company engaged in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin, insulin series, antibiotics, ophthalmic products, veterinary drugs, 6-aminopenicillanic acid, and penicillin G potassium. It also provides endocrine and metabolism, anti-infection, and other human-used finished products, as well as health and wellness products such as dietary supplements, healthcare foods, cross-border nutritional supplements, and medical and aesthetic skincare products. Additionally, it conducts research, development, production, sale, and technical services for economic and companion animal medicines. The company operates in the People's Republic of China, India, Europe, the Middle East, South America, other Asian regions, and internationally. Founded in 1990, it is headquartered in Yuen Long, Hong Kong.